← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
CBIZ grew revenue, remained profitable, generated positive free cash flow at a 8.5% operating margin. Acquisition-supported revenue growth was strong, but margins and free cash flow were more modest.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 52.1%OK
- Profitability — Net income grew 181.3% to $115.444M from $41.038MOK
- Cash flow — Free cash flow grew 58.4% to $175.526M from $110.778MOK
- Margins — Operating margin expanded 442 bps to 8.48%OK
- Accounting — Acquisition-supported revenue growth was strong, but margins and free cash flow were more modestNote
- Insiders — 5 purchases and 2 salesOK
Business
CBIZ provides accounting, benefits and advisory services.
Where the revenue comes from
Fiscal 2025, as CBIZ, Inc. reports it. History and quarterly detail are in the app.
- Financial Services$2.3B
- Benefits and Insurance Services$409.6M
- National Practices$46.9M
Leadership changes
From CBIZ, Inc.'s own filings, the day they're filed.
- Chris Spurio · President · departureeff. 2026-01-31
- Michael Mangan · Chief Accounting Officer · departureeff. 2025-03-17
- Kathy A. Raffa · director · appointmenteff. 2025-01-15
Latest filings
- 10-Q · Quarterly report2026-08-04
- 8-K · Company announcement2026-07-29
- 8-K · Company announcement2026-07-29
- 8-K · Company announcement2026-07-29
- 8-K · Company announcement2026-05-15
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about CBIZ, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.